Hanxuan Yang
Fuzhou, 350014, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pseudogene pair-based prognostic model reveals LAT as a biomarker of immune response in head and neck squamous cell carcinoma.
Journal: Discover oncology
Published: May 15, 2025
The key role of DLX6 in nasopharyngeal carcinoma: metastasis, angiogenesis and tumor immune mechanism.
Journal: Frontiers in immunology
Published: November 04, 2024
Inhibition of PNCK inflames tumor microenvironment and sensitizes head and neck squamous cell carcinoma to immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: September 26, 2024
m6A methylation profiling as a prognostic marker in nasopharyngeal carcinoma: insights from MeRIP-Seq and RNA-Seq.
Journal: Frontiers in immunology
Published: September 07, 2024
Integrative single cell transcriptomic analysis reveals 3p deletion associated tumor microenvironment and chemoresistance in head and neck squamous cell carcinoma.
Journal: Scientific reports
Published: September 02, 2024
Magnesium-related gene ITGAL: a key immunotherapy predictor and prognostic biomarker in pan-cancer.
Journal: Frontiers in pharmacology
Published: July 15, 2024
The causal impact of complement C3d receptor 2 on head and neck cancer microenvironment and its implications for immunotherapy response prediction.
Journal: Heliyon
Published: February 15, 2024
Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma.
Journal: British journal of cancer
Published: May 23, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026